Methamphetamine pharmacological properties

Bupropion (amfebutamone) is a phenylisopropylaminoketone that is structurally related to the phenylisopropylamine CNS stimulant, methamphetamine, and the phenylisopropylaminoketone, cathinone (a constituent in khat), and the anorexiant, diethylpropion (Fig. 21.21). Although structurally similar to the CNS stimulants, bupropion exhibits distinctive different pharmacologic and therapeutic effects. The absence of the tricyclic ring system in bupropion results in a better adverse-effect profile than with the TCAs. The tertiary butyl group in bupropion prevents its N-dealkylation to metabolites that could possess sympathomimetic and/or anorexigenic properties. 

---